Primary scale-up bioreactors containing insect cells for the production of VaxSyn, an experimental AIDS vaccine. VaxSyn is based on a genetically-engineered, recombinant form of the HIV protein gp160, which is a precursor to one of HIV's surface proteins. VaxSyn is genetically- engineered from the baculovirus (an insect virus), with insect cell cultures used in the scale-up process. VaxSyn contains no attenuated infectious parts of HIV & therefore carries no risk of transmitting AIDS. The vaccine is being developed by MicroGeneSys and is undergoing trials as a treatment of HIV-positive patients & as a potential vaccine against HIV infection.
px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TOP10187140
Source:
達志影像
Authorization Type:
RM
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images: